3M Personal Protective Equipment (PPE) Considerations
The symptoms of the illness associated with this novel coronavirus are similar to those caused by influenza and other respiratory illnesses and include coughing, shortness of breath, fever, and difficulty breathing. In many countries, COVID-19 is considered to be a high-risk workplace hazard for healthcare workers in a variety of fields and specializations. The WHO and U.S. Centers for Disease Control and Prevention (CDC) have recommended airborne precautions for healthcare workers for certain interactions with patients with suspected or known cases of COVID-19.
3M is committed to supporting the public health and government response to the COVID-19 pandemic. 3M has ramped up production at its manufacturing facilities around the world – and continues to do so further – and is working with customers, distributors, government and medical officials to help get supplies to where they are most needed.
In this crisis, 3M is experiencing unprecedented demand for respirators.
3M is partnering with other companies on a range of innovative solutions to protect healthcare workers and first responders.
Ford - with consulting support from 3M - has developed a unique powered-air purifying respirator (PAPR) for use in reducing exposure to airborne particles.
In early April, 3M reached agreement with the U.S. government on a plan that will enable FEMA to import 166.5 million respirators into the United States over a 3-month period starting in April, from our plants in Asia.
Every day, health care workers on the front lines put themselves at risk to ensure others are cared for. 3M Medical offers resources and information to help protect providers and patients, especially during this challenging time.